Macleods Pharma USA

With a vision to provide quality healthcare to humanity and a special focus on essential medicines that are difficult to manufacture, Macleods Pharma USA, Inc. began operations in the U.S. in 2012. Macleods has enjoyed rapid growth in recent years, growing at an average rate of over 84% in terms of volume over the past 5 years. Macleods, with suppo... rt from its Parent company based in Mumbai, India, brings experience spanning more than four decades. With over 15,000 professionally qualified employees across the globe, Macleods has emerged as a strong presence in both the global and U.S. pharmaceutical market. Macleods provides medications for both chronic and acute therapy, with world class state-of-the-art manufacturing facilities approved by various international authorities and well equipped R&D, analytical and bioequivalence centers making Macleods a truly global pharmaceutical company. The company currently holds over 70 approvals with the U.S. Food and Drug Administration and is vertically integrated with API on over 85% of its US portfolio. With expertise in a wide variety of formulations ranging from tablets to sterile dosage form and from inhalation to novel drug delivery systems, Macleods is currently one of the Top 10 companies in the Indian Pharmaceutical Industry and is recognized as one of the fastest-growing pharmaceutical companies in India as well as the U.S. market. 2020 marks the culmination of several block capacity expansions of the company's facilities for API and finished dose as well as a brand new finished dose manufacturing facility all in support of the US market.Read More